Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd (AGARWALEYE) last reported results for the quarter ended Jun 2026, with sales of ₹614 crore and net profit of ₹55 crore. The stock last traded at ₹479, a market capitalisation of ₹15,181 crore, on a P/E of 103. Over the past 52 weeks the stock has ranged between ₹401 and ₹568. Figures are as of 6 Oct 2026 and are not real time.
Dr. Agarwals Health Care Ltd share price and key metrics
- Current price
- ₹479
- Market cap
- ₹15,181 cr
- Stock P/E
- 103
- Book value
- ₹63.9
- ROE
- 5.99%
- ROCE
- 10.9%
- Dividend yield
- 0.00%
- 52w high / low
- 568/401
Metrics as of 6 Oct 2026. Not real time.
Track Dr. Agarwals Health Care Ltd
Cruxal reads every Dr. Agarwals Health Care Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Dr. Agarwals Health Care Ltd growth and returns
- 10 Years
- %
- 5 Years
- 35%
- 3 Years
- 27%
- TTM
- 23%
- 10 Years
- %
- 5 Years
- 33%
- 3 Years
- 9%
- TTM
- 43%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -1%
- 10 Years
- %
- 5 Years
- 7%
- 3 Years
- 6%
- Last Year
- 6%
Dr. Agarwals Health Care Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹614 cr, up 26.1% from ₹487 cr a year earlier. Net profit was ₹55 cr, up 44.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 417 | 431 | 460 | 487 | 499 | 530 | 564 | 614 |
| Expenses | 310 | 316 | 329 | 360 | 363 | 386 | 403 | 444 |
| Operating profit | 107 | 115 | 131 | 128 | 136 | 144 | 161 | 170 |
| OPM % | 26% | 27% | 28% | 26% | 27% | 27% | 29% | 28% |
| Other income | 12 | 13 | 13 | 13 | 8 | 11 | 14 | 6 |
| Interest | 28 | 28 | 25 | 25 | 23 | 21 | 22 | 23 |
| Depreciation | 57 | 58 | 60 | 63 | 68 | 69 | 77 | 78 |
| Profit before tax | 33 | 41 | 59 | 54 | 54 | 65 | 77 | 75 |
| Tax % | 36% | 31% | 27% | 29% | 32% | 33% | 35% | 27% |
| Net profit | 21 | 28 | 43 | 38 | 36 | 44 | 50 | 55 |
| EPS (₹) | — | 0.72 | 1.03 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Dr. Agarwals Health Care Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 531 | 471 | 696 | 1,018 | 1,332 | 1,711 | 2,080 | 2,207 |
| Operating profit | 124 | 85 | 186 | 275 | 367 | 463 | 577 | 612 |
| OPM % | 23% | 18% | 27% | 27% | 28% | 27% | 28% | 28% |
| Net profit | -21 | -59 | 43 | 103 | 95 | 110 | 168 | 185 |
| EPS (₹) | — | — | — | — | — | 2.64 | 4.20 | 4.69 |
TTM is the trailing twelve months to the most recent quarter.
Dr. Agarwals Health Care Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 7 | 7 | 7 | 8 | 9 | 32 | 32 |
| Reserves | 242 | 177 | 206 | 622 | 1,330 | 1,835 | 1,994 |
| Borrowings | 162 | 185 | 633 | 857 | 966 | 961 | 1,066 |
| Other liabilities | 339 | 417 | 179 | 336 | 445 | 837 | 849 |
| Total liabilities | 751 | 787 | 1,025 | 1,823 | 2,751 | 3,665 | 3,941 |
| Fixed assets | 551 | 575 | 701 | 1,293 | 1,746 | 2,523 | 2,870 |
| CWIP | 8 | 11 | 28 | 99 | 118 | 153 | 244 |
| Investments | 1 | 0 | 0 | 34 | 471 | 264 | 152 |
| Other assets | 192 | 201 | 295 | 397 | 416 | 724 | 675 |
| Total assets | 751 | 787 | 1,025 | 1,823 | 2,751 | 3,665 | 3,941 |
As reported by the company. Total assets equal total liabilities by construction.
Dr. Agarwals Health Care Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 103 | 99 | 164 | 233 | 346 | 357 | 519 |
| Cash from investing | -85 | -46 | -155 | -509 | -914 | -750 | -308 |
| Cash from financing | -73 | -37 | 35 | 303 | 553 | 382 | -220 |
| Net cash flow | -56 | 17 | 44 | 27 | -15 | -11 | -10 |
| Free cash flow | -98 | 66 | 95 | 76 | 118 | 37 | 59 |
| CFO / operating profit | 97% | 126% | 97% | 98% | 103% | 85% | 99% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Dr. Agarwals Health Care Ltd operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | -1% | 17% | 13% | 11% | 10% | 11% |
| Debtor days | 36 | 36 | 30 | 27 | 27 | 26 | 28 |
| Inventory days | 178 | 169 | 144 | 116 | 138 | 181 | 178 |
| Days payable | 340 | 452 | 389 | 326 | 355 | 286 | 283 |
| Cash conversion cycle | -126 | -247 | -215 | -183 | -190 | -79 | -76 |
| Working capital days | -31 | -47 | -50 | -62 | -65 | -43 | -30 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Dr. Agarwals Health Care Ltd shareholding pattern
Promoters held 32.34% at Jun 2026, broadly unchanged since Jun 2025. FIIs 57.97% and DIIs 7.72%.
| % held | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 32.45% | 32.43% | 32.43% | 32.39% | 32.35% | 32.34% |
| FIIs | 60.62% | 59.26% | 58.13% | 58.06% | 57.94% | 57.97% |
| DIIs | 5.21% | 6.44% | 7.92% | 7.78% | 7.83% | 7.72% |
| Public | 1.74% | 1.87% | 1.52% | 1.78% | 1.87% | 1.97% |
| No. of shareholders | 68,696 | 63,021 | 48,168 | 46,554 | 43,538 | 42,492 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Dr. Agarwals Health Care Ltd corporate filings
- Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, is enclosed.Company Updatelow impact
- NCLT Sanctions Scheme of Amalgamation Between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited, Effective from April 01, 2026Company Updatemedium impact
Cruxal's analysis: Dr. Agarwal’s Eye Hospital Limited (AEHL) has received approval from the National Company…
Read the full analysis - Update on Step-down wholly owned subsidiary in Nigeria by Orbit Healthcare Services (Mauritius) Limited, a direct wholly owned subsidiary of the Company.Company Updatemedium impact
- Completion of Second Term of 5 (Five) Consecutive Years by Mr. Sanjay Anand (DIN: 02501139), Independent Director of the CompanyCompany Updatemedium impact
- Closure of Trading Window pursuant to Dr. Agarwals Health Care Limited - Code of Conduct for Prevention of Insider TradingInsider Trading / SASTlow impact
- Dr. Agarwal's Health Care Limited Announces Successful Conclusion of 16th Annual General Meeting and Shareholder Approval of All ResolutionsAGM/EGMlow impact
Cruxal's analysis: Dr. Agarwal's Health Care Limited has successfully concluded its 16th Annual General…
Read the full analysis - Dr. Agarwal's Health Care Limited concludes 16th AGM; shareholders approve financial statements and leadership remunerationAGM/EGMlow impact
Cruxal's analysis: Dr. Agarwal's Health Care Limited has successfully concluded its 16th Annual General…
Read the full analysis - Dr. Agarwals Health Care Limited announces Sixteenth Annual General Meeting and e-voting instructionsCompany Updatelow impact
Cruxal's analysis: Dr. Agarwals Health Care Limited has published a newspaper advertisement regarding its…
Read the full analysis - Dr. Agarwals Health Care Ltd submits Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Dr. Agarwals Health Care Ltd has filed its Annual Report for the financial year 2025-26…
Read the full analysis - Dr. Agarwal’s Health Care Limited Announces 16th Annual General Meeting for September 21, 2026AGM/EGMlow impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited has issued a notice for its 16th Annual General Meeting…
Read the full analysis - Dr. Agarwals Eye Hospital launches world's first Pinhole Pupilloplasty (PPP) centreCompany Updatelow impact
Cruxal's analysis: Dr. Agarwals Health Care Ltd announced that its subsidiary, Dr. Agarwals Eye Hospital…
Read the full analysis - Dr. Agarwals Health Care Ltd schedules analyst and investor meetingCompany Updatelow impact
Cruxal's analysis: Dr. Agarwals Health Care Ltd has submitted an intimation regarding a scheduled meeting…
Read the full analysis - Dr. Agarwal’s Health Care Limited: Pledge creation of 75.38 lakh shares (2.38% stake) by Catalyst Trusteeship LimitedInsider Trading / SASTmedium impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited has reported a fresh pledge creation of 75.38 lakh…
Read the full analysis - Dr. Agarwal’s Health Care Limited: Shareholder Hyperion Investments Disposes 2.41 Crore Shares Following Partial Pledge ReleaseInsider Trading / SASTmedium impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited (the 'Target Company') has seen a significant change in…
Read the full analysis - Claymore Investments (Mauritius) Pte. Ltd. Divests 1.59 Crore Shares of Dr. Agarwals Health Care Limited via Open MarketInsider Trading / SASTmedium impact
Cruxal's analysis: Dr. Agarwals Health Care Limited has witnessed a significant stake sale by a major…
Read the full analysis - Hyperion Investments Sells 2.41 Crore Shares of Dr. Agarwal’s Health Care Limited via Open MarketInsider Trading / SASThigh impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited faces a significant stake sale by a major institutional…
Read the full analysis - Invesco Mutual Fund increases stake in Dr. Agarwal's Healthcare Limited to 5.21%Insider Trading / SASTmedium impact
Cruxal's analysis: Invesco Mutual Fund has disclosed an acquisition of 69.38 lakh equity shares of Dr…
Read the full analysis - Dr. Agarwal’s Health Care Limited: Partial Release of Promoter-Linked Share PledgeInsider Trading / SASTmedium impact
Cruxal's analysis: Dr. Agarwal’s Health Care Limited has reported a partial release of encumbrance over 3.17…
Read the full analysis - ICICI Prudential Mutual Fund acquires 5.36% stake in Dr. Agarwal's Health Care Limited via open marketInsider Trading / SASTmedium impact
Cruxal's analysis: ICICI Prudential Mutual Fund has disclosed the acquisition of 1 crore 69 lakh 99 thousand…
Read the full analysis - Dr. Agarwal's Healthcare reports strong Q1 FY27 performance with 26% revenue growth and record facility expansionCompany Updatehigh impact
Cruxal's analysis: Dr. Agarwal's Healthcare Limited delivered robust Q1 FY27 results, with revenue from…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.